Correction to: Cell Death and Disease https://doi.org/10.1038/s41419-022-05304-8, published online 08 October 2022
The original version of this article contained two errors in Fig. 3C and Fig. 6B: in Fig. 3C, the merged image of the control GL261 cells was inadvertently duplicated and presented as both the DAPI and Merge images; in Fig. 6B, the liver image of the RXD+TMZ group was inadvertently duplicated and presented as both RXD and RXD+TMZ group livers. The source data files were not affected by the errors, and contain the correct images for all the groups. The authors apologize for the errors. The errors have been corrected in both the PDF and HTML versions of the Article.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Su, X., Xie, Y., Zhang, J. et al. Correction: HIF-α activation by the prolyl hydroxylase inhibitor roxadustat suppresses chemoresistant glioblastoma growth by inducing ferroptosis. Cell Death Dis 14, 31 (2023). https://doi.org/10.1038/s41419-022-05532-y
Published:
DOI: https://doi.org/10.1038/s41419-022-05532-y
